Synergy Pharmaceuticals (SGYP) PT Lowered to $7 at BTIG; 'Factoring Risk of Additional Equity Financings by Late CY18 / Early CY19
Tweet Send to a Friend
BTIG lowered its price target on Synergy Pharmaceuticals (NASDAQ: SGYP) to $7.00 (from $11.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
